Medisign Pharmaceuticals Llp - Company Profile

It is a healthcare limited liability partnership based in Ahmedabad, Gujarat, India, established in 2016.
2016 Ahmedabad, Gujarat, India Active
Last Updated:
About Medisign Pharmaceuticals Llp

Medisign Pharmaceuticals Llp, a active limited liability partnership, was established on 16 December 2016 in Ahmedabad, Gujarat, India. Engaging in health and social work within the healthcare sector, it holds LLPIN: AAI-0269. Registered under ROC Roc Ahmedabad. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Kapil Keshavlal Gohel (Designated Partner), Vishal Jadav Virendrabhai (Designated Partner). Past directors included Pravinbhai Bhagvanbhai Gohil. Its latest date of accounts and solvency statement 31 March 2020. It is based at 503, Samudra Annexe, Nr Hotel Saffron Girish Cold Drinks, C G Road, Navrangpur, A, Ahmedabad, Gujarat, 380005.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAI-0269

  • Incorporation Date

    16 December 2016

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 9 Year, 1 Month
  • Last Filing with ROC 31 Mar 2020
Company report

Medisign Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medisign Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Medisign Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Kapil Keshavlal Gohel Designated Partner 16 Dec 2016 Current
Vishal Jadav Virendrabhai Designated Partner 16 Dec 2016 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medisign Pharmaceuticals Llp.

Enhance accessibility to Medisign Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Medisign Pharmaceuticals Llp revenue growth over time
Medisign Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medisign Pharmaceuticals Llp?

Unlock access to Medisign Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Medisign Pharmaceuticals Llp?

Unlock and access historical data on people associated with Medisign Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medisign Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medisign Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medisign Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Medisign Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2020 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    Medisign Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    Progress on Kapil Keshavlal Gohel was appointed as a Designated Partner was appointed as a Designated Partner on 16 Dec 2016 & has been associated with this company since 9 years 1 month . was documented.

  • Director Appointment

    The activity Vishal Jadav Virendrabhai was appointed as a Designated Partner was appointed as a Designated Partner on 16 Dec 2016 & has been associated with this company since 9 years 1 month . was completed.

  • LLP Incorporation

    Progress on Medisign Pharmaceuticals Llp was registered on 16 Dec 2016 with Roc Ahmedabad & aged 9 years 1 month as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Medisign Pharmaceuticals Llp?

The LLPIN of Medisign Pharmaceuticals Llp is AAI-0269.

Where is Medisign Pharmaceuticals Llp headquartered?

Medisign Pharmaceuticals Llp is headquartered at 503, Samudra Annexe, Nr Hotel Saffron Girish Cold Drinks, C G Road, Navrangpur, A, Ahmedabad, Gujarat, 380005.

When was Medisign Pharmaceuticals Llp incorporated?

Medisign Pharmaceuticals Llp was incorporated on 16 December 2016.

Who are the current directors of Medisign Pharmaceuticals Llp?

The current directors of Medisign Pharmaceuticals Llp are

What is the primary industry of Medisign Pharmaceuticals Llp?

The primary industry of Medisign Pharmaceuticals Llp is Healthcare.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available